{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:27:01Z","timestamp":1762100821076},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.fpc.0000167326.00411.50","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T12:19:44Z","timestamp":1209903584000},"page":"503-511","source":"Crossref","is-referenced-by-count":29,"title":["Theophylline pharmacokinetics: comparison of Cyp1a1(\u2212\/\u2212) and Cyp1a2(\u2212\/\u2212) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+\/+) wild-type mice"],"prefix":"10.1097","volume":"15","author":[{"given":"Sandrine","family":"Derkenne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine P.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard G.","family":"Shertzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Dragin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Nebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI111843","article-title":"Polymorphism of theophylline metabolism in man","volume":"75","author":"Miller","year":"1985","journal-title":"J Clin Invest"},{"key":"R2-8-20210212","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0024-3205(75)90503-2","article-title":"Decreased theophylline half-life in cigarette smokers","volume":"17","author":"Jenne","year":"1975","journal-title":"Life Sci"},{"key":"R3-8-20210212","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cpt1976195part1546","article-title":"Effect of smoking on theophylline disposition","volume":"19","author":"Hunt","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/clpt.1981.193","article-title":"Cigarette smoking and theophylline clearance and metabolism","volume":"30","author":"Grygiel","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R5-8-20210212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt1977213310","article-title":"Theophylline kinetics in acute pulmonary edema","volume":"21","author":"Piafsky","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJM197706302962603","article-title":"Theophylline disposition in patients with hepatic cirrhosis","volume":"296","author":"Piafsky","year":"1977","journal-title":"N Engl J Med"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2165\/00003088-199121050-00007","article-title":"Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report","volume":"21","author":"Leakey","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1378\/chest.98.6.1440","article-title":"The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man","volume":"98","author":"Wijnands","year":"1990","journal-title":"Chest"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00194956","article-title":"Effects of lansoprazole on pharmacokinetics and metabolism of theophylline","volume":"48","author":"Kokufu","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"R10-8-20210212","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1177\/0091270003257454","article-title":"An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe","volume":"43","author":"Bachmann","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-197803040-00002","article-title":"Clinical pharmacokinetics of theophylline","volume":"3","author":"Ogilvie","year":"1978","journal-title":"Clin Pharmacokinet"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cpt1979265660","article-title":"Effects of allopurinol on theophylline metabolism and clearance","volume":"26","author":"Grygiel","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"R13-8-20210212","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/0006-2952(88)90423-6","article-title":"Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies","volume":"37","author":"Robson","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"R14-8-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2125.1995.tb04422.x","article-title":"Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine","volume":"39","author":"Rasmussen","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"R15-8-20210212","first-page":"912","article-title":"Theophylline metabolism in human liver microsomes: inhibition studies","volume":"276","author":"Tjia","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R16-8-20210212","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/00498258509045346","article-title":"Dose-dependent elimination of theophylline in rats","volume":"15","author":"Teunissen","year":"1985","journal-title":"Xenobiotica"},{"key":"R17-8-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-5173(99)00111-8","article-title":"Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats","volume":"184","author":"Han","year":"1999","journal-title":"Int J Pharm"},{"key":"R18-8-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00498259409043242","article-title":"In vitro metabolism of theophylline by rat and human liver tissue","volume":"24","author":"Salyers","year":"1994","journal-title":"Xenobiotica"},{"key":"R19-8-20210212","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1995.tb04455.x","article-title":"Metabolism of theophylline by cDNA-expressed human cytochromes P450","volume":"39","author":"Ha","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"R20-8-20210212","first-page":"31","article-title":"Characterization of human liver cytochromes P-450 involved in theophylline metabolism","volume":"20","author":"Sarkar","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","article-title":"Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1","volume":"2","author":"Gu","year":"1992","journal-title":"Pharmacogenetics"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-2952(95)00120-O","article-title":"Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation","volume":"50","author":"Zhang","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"R23-8-20210212","first-page":"827","article-title":"Theophylline N-demethylations as probes for P450 1A1 and P450 1A2","volume":"22","author":"Sarkar","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-2952(92)90282-N","article-title":"Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms","volume":"43","author":"Fuhr","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"R25-8-20210212","first-page":"617","article-title":"Oxidation of xenobiotics by recombinant human cytochrome P450 1B1","volume":"25","author":"Shimada","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J Biol Chem"},{"key":"R27-8-20210212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003088-199500291-00005","article-title":"Drug interactions and the cytochrome P450 system The role of cytochrome P450 1A2","volume":"29","author":"Brosen","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-199510000-00001","article-title":"Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity","volume":"5","author":"Eaton","year":"1995","journal-title":"Pharmacogenetics"},{"key":"R29-8-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/bbrc.1999.1913","article-title":"Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ahr] battery","volume":"267","author":"Dalton","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-8-20210212","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.93.4.1671","article-title":"Cyp1a2(\u2212\/\u2212) null mutant mice develop normally but show deficient drug metabolism","volume":"93","author":"Liang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-8-20210212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/humu.20134","article-title":"Toward the evaluation of function in genetic variability: characterizing human SNPs and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus","volume":"25","author":"Jiang","year":"2005","journal-title":"Hum Mutat"},{"key":"R32-8-20210212","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2000.tb06876.x","article-title":"\u2018Gene-swap knock-in\u2019 cassette in mice to study allelic differences in human genes","volume":"919","author":"Nebert","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"R33-8-20210212","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/002367798780599866","article-title":"Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink","volume":"32","author":"Hem","year":"1998","journal-title":"Lab Anim"},{"key":"R34-8-20210212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-4347(95)00374-6","article-title":"Determination of theophylline and its metabolites in human urine and plasma by high-performance liquid chromatography","volume":"676","author":"Rasmussen","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R35-8-20210212","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0731-7085(89)80021-4","article-title":"Separation and determination of theophylline from paraxanthine in human serum by reversed-phase high-performance liquid chromatography","volume":"7","author":"Kawakatsu","year":"1989","journal-title":"J Pharm Biomed Anal"},{"key":"R36-8-20210212","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0731-7085(95)01581-7","article-title":"An isocratic high-performance liquid chromatographic system for simultaneous determination of theophylline and its major metabolites in human urine","volume":"13","author":"Tajerzadeh","year":"1995","journal-title":"J Pharm Biomed Anal"},{"key":"R37-8-20210212","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1006\/bbrc.2001.6110","article-title":"Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(\u2212\/\u2212) knockout mice having increased hepatic BaP-DNA adduct levels","volume":"289","author":"Uno","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R38-8-20210212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0003-2697(88)90555-6","article-title":"Mixed anionic detergent\/aliphatic alcohol\u2013polyacrylamide gel electrophoresis alters the separation of proteins relative to conventional sodium dodecyl sulfate\u2013polyacrylamide gel electrophoresis","volume":"174","author":"Brown","year":"1988","journal-title":"Anal Biochem"},{"key":"R39-8-20210212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/taap.1998.8501","article-title":"Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice","volume":"152","author":"Zaher","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"R40-8-20210212","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.1998.8543","article-title":"Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice","volume":"153","author":"Tonge","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"R41-8-20210212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-199608000-00002","article-title":"Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2","volume":"6","author":"Buters","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R42-8-20210212","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0006-2952(02)01019-5","article-title":"Differences in caffeine and paraxanthine metabolism between human and mouse CYP1A2","volume":"63","author":"Labedzki","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"R43-8-20210212","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/clpt.1993.63","article-title":"The use of caffeine for enzyme assays: a critical appraisal","volume":"53","author":"Kalow","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R44-8-20210212","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1021\/bi00435a026","article-title":"Identification of a novel P450 expressed in rat lung: cDNA cloning and sequence, chromosome mapping, and induction by 3-methylcholanthrene","volume":"28","author":"Kimura","year":"1989","journal-title":"Biochemistry"},{"key":"R45-8-20210212","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"key":"R46-8-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/mol.61.2.255","article-title":"Identification of a novel dioxin-inducible cytochrome P450","volume":"61","author":"Rivera","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R47-8-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00365519709060032","article-title":"Elimination of theophylline metabolites in healthy adults","volume":"57","author":"Rodopoulos","year":"1997","journal-title":"Scand J Clin Lab Invest"},{"key":"R48-8-20210212","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/00912700122010979","article-title":"Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects","volume":"41","author":"Zhou","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"R49-8-20210212","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cpt1976193375","article-title":"Relationship of urinary metabolites of theophylline to serum theophylline levels","volume":"19","author":"Jenne","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"R50-8-20210212","first-page":"268","article-title":"Biodisposition of theophylline. I. Genetic variation in inbred mice","volume":"8","author":"Betlach","year":"1980","journal-title":"Drug Metab Dispos"},{"key":"R51-8-20210212","first-page":"271","article-title":"Biodisposition of theophylline. II. Effect of aromatic hydrocarbon treatment in mice","volume":"8","author":"Betlach","year":"1980","journal-title":"Drug Metab Dispos"},{"key":"R52-8-20210212","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0378-4347(00)81638-2","article-title":"Urinary excretion of methylated purines in man and in the rat after the administration of theophylline","volume":"163","author":"van Gennip","year":"1979","journal-title":"J Chromatogr"},{"key":"R53-8-20210212","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3476(77)81051-2","article-title":"Dose-dependent kinetics of theophylline disposition in asthmatic children","volume":"91","author":"Weinberger","year":"1977","journal-title":"J Pediatr"},{"key":"R54-8-20210212","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-3476(80)80280-0","article-title":"Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children","volume":"97","author":"Sarrazin","year":"1980","journal-title":"J Pediatr"},{"key":"R55-8-20210212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jps.10531","article-title":"Interspecies scaling of protein drugs: prediction of clearance from animals to humans","volume":"93","author":"Mahmood","year":"2004","journal-title":"J Pharm Sci"},{"key":"R56-8-20210212","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dna.1996.15.273","article-title":"Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer","volume":"15","author":"Nebert","year":"1996","journal-title":"DNA Cell Biol"},{"key":"R58-8-20210212","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejphar.2004.07.031","article-title":"Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead","volume":"500","author":"Nebert","year":"2004","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000167326.00411.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:40:35Z","timestamp":1620938435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200507000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000167326.00411.50","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}